Luhan Pharmachem Co., Ltd.

Home > Products > APIs > Oncology >

DOCETAXEL TRIHYDRATE

Luhan pharmachem Co., Ltd. supplies Docetaxel Trihydrate bulk active pharmaceutical ingredient (API) to the pharmaceutical industry. Our Docetaxel Trihydrate is manufactured by cGMP compliant facility. Welcome to contact us for further details including current DMF status for the product and up to date regulatory status of the manufacturing facility. We look forward to assisting you with your research and development projects.

What is Docetaxel Trihydrate?

The trihydrate form of docetaxel. It is used for the treatment of breast, ovarian, and non-small cell lung cancer, and with prednisone or prednisolone in hormone-refractory metastatic prostate cancer.


More  information

CAS No.:148408-66-6


Description

This compound acts as an antineoplastic, as well as an antimitotic agent that promotes the assembly of microtublules which inhibits their depolymerization to free tubulin.

Disclaimer:

Information on this page is provided for general information purposes. You should not make a clinical treatment decision based on information contained in this page without consulting other references including the package insert of the drug, textbooks and where relevant, expert opinion. We cannot be held responsible for any errors you make in administering drugs mentioned on this page, nor for use of any erroneous information contained on this page.

About Us

Company Profile

Advantages

Strong R & D center

Qualifications

Products

APIs

Intermediates & Extracts

In development

Services

API Sourcing and Regulatory Support

Custom Synthesis

Logistics and Customs Clearance

Contact Us

Tel: +86 0871 6511 0906 (GMT+8 AM9:00-AM:12:00 PM1:30-PM6:00)

cell phone:188 1221 6310

Fax:0871-63602606

Email: info@luhancn.com

Address:Room 3301,33rd Floor Building B, Vogue Garden Plaza, No.1004 Beijing Road, Kunming, Yunnan Province, P. R. China 650000